Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE AND TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic useInitial U.S. Approval: 2007
Medication labelWhy this: Advisory · dailymed-prescription
Brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%/0.5% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%/0.5% dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day.
- generic_name
- brimonidine tartrate and timolol maleate
- product_names
- Brimonidine Tartrate and Timolol Maleate
- ndc
- 0781-7186, 0781-7186-75, 0781-7186-70, 0781-7186-85
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en